These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis. Malter MP; Elger CE; Surges R Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046 [TBL] [Abstract][Full Text] [Related]
23. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732 [TBL] [Abstract][Full Text] [Related]
24. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy. Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997 [TBL] [Abstract][Full Text] [Related]
25. [Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications]. Dalmau J; Bataller L Neurologia; 2007 Oct; 22(8):526-37. PubMed ID: 18000762 [TBL] [Abstract][Full Text] [Related]
26. Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Jaster JH Neurology; 2004 Oct; 63(7):1339; author reply 1339. PubMed ID: 15477575 [No Abstract] [Full Text] [Related]
27. Comparison of the cytokine profiles of patients with neuronal-antibody-associated central nervous system disorders. Ulusoy C; Tüzün E; Kürtüncü M; Türkoğlu R; Akman-Demir G; Eraksoy M Int J Neurosci; 2012 Jun; 122(6):284-9. PubMed ID: 22176581 [TBL] [Abstract][Full Text] [Related]
30. Paraneoplastic neurological syndromes in patients with carcinoid. Tschernatsch M; Dierkes C; Gerriets T; Hosch J; Stolz E; Kaps M; Krasenbrink I; Claus D; Blaes F Eur J Neurol; 2008 Dec; 15(12):1390-4. PubMed ID: 19049559 [TBL] [Abstract][Full Text] [Related]
31. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Graus F; Lang B; Pozo-Rosich P; Saiz A; Casamitjana R; Vincent A Neurology; 2002 Sep; 59(5):764-6. PubMed ID: 12221175 [TBL] [Abstract][Full Text] [Related]
32. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES. van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482 [TBL] [Abstract][Full Text] [Related]
33. Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology. Dubey D; Alqallaf A; Hays R; Freeman M; Chen K; Ding K; Agostini M; Vernino S JAMA Neurol; 2017 Apr; 74(4):397-402. PubMed ID: 28166327 [TBL] [Abstract][Full Text] [Related]
34. [Autoantibodies in Paraneoplastic Neurological Syndrome]. Kawachi I Brain Nerve; 2018 Apr; 70(4):329-339. PubMed ID: 29632281 [TBL] [Abstract][Full Text] [Related]
35. Prevalence and outcome of late-onset seizures due to autoimmune etiology: A prospective observational population-based cohort study. von Podewils F; Suesse M; Geithner J; Gaida B; Wang ZI; Lange J; Dressel A; Grothe M; Kessler C; Langner S; Runge U; Bien CG Epilepsia; 2017 Sep; 58(9):1542-1550. PubMed ID: 28681401 [TBL] [Abstract][Full Text] [Related]